| References: |
Endogenous aryl hydrocarbon receptor (AhR) agonist (Ki = 3 nM). Decreases Oct4 levels in U87 glioblastoma cells. Induces stem-like cancer cell differentiation in U87 tumor spheres in vitro and suppresses tumor growth in U87 cell xenografts in mice. Also inhibits TGF-β-induced human myofibroblast differentiation. For the detailed information of ITE, the solubility of ITE in water, the solubility of ITE in DMSO, the solubility of ITE in PBS buffer, the animal experiment (test) of ITE, the cell expriment (test) of ITE, the in vivo, in vitro and clinical trial test of ITE, the EC50, IC50,and affinity,of ITE, For the detailed information of ITE, the solubility of ITE in water, the solubility of ITE in DMSO, the solubility of ITE in PBS buffer, the animal experiment (test) of ITE, the cell expriment (test) of ITE, the in vivo, in vitro and clinical trial test of ITE, the EC50, IC50,and affinity,of ITE, Please contact DC Chemicals. |
